The wearable technology industry is facing a significant legal challenge as Oura, a prominent leader in the smart ring market, has become the subject of a class action lawsuit alleging that the company’s marketing claims regarding sleep tracking accuracy are fundamentally deceptive. Filed in the United States District Court for the Northern District of California, […]
A Partnership-driven Approach to Waste and Abuse Prevention
Healthcare payers are currently grappling with an escalation in Fraud, Waste, and Abuse (FWA) risks that have begun to outpace the capabilities of traditional oversight controls. While the industry has historically relied on a "pay-and-chase" model—whereby improper payments are identified and recovered after they have been disbursed—this approach is increasingly viewed as inefficient, costly, and […]
Expressable Becomes First Speech Therapy Provider to Join Amazon Health Benefits Connector
In a significant expansion of its digital health ecosystem, Amazon has announced the addition of Expressable as the inaugural speech therapy provider within its Health Benefits Connector platform. This strategic collaboration aims to streamline the process for Amazon customers to identify, verify, and utilize employer-sponsored and insurance-covered speech and language services. By integrating Expressable’s virtual […]
Ascension Saint Thomas Midtown Investigation Intensifies After Major Medication Error Leaves Patient Paralyzed and Sparks Criminal Probe
The healthcare community in Nashville and across the United States is closely monitoring the fallout from a significant medication error at Ascension Saint Thomas Midtown hospital, which has resulted in life-altering injuries for patients and a burgeoning criminal investigation. Ascension, one of the nation’s largest non-profit health systems, confirmed this week that a pharmacy-related mistake […]
Roche Secures Global Rights to Hanmi Pharmaceuticals Muscle-Preserving Obesity Drug HM17321 in 2.5 Billion Dollar Deal
In a strategic move to solidify its presence in the rapidly evolving metabolic health sector, Roche has announced an exclusive licensing agreement with Hanmi Pharmaceutical for the development and commercialization of HM17321, a clinical-stage investigational therapy designed to address obesity while preserving muscle mass. The agreement, executed through Roche’s Genentech subsidiary, involves an upfront payment […]
Cityblock Acquires Homeward Health and Secures 116 Million Dollars in Series E Funding to Scale Value-Based Rural Care
Cityblock, a leading value-based healthcare provider specializing in marginalized and complex patient populations, has announced the acquisition of Homeward Health in an all-stock transaction, alongside a successful $116 million Series E funding round. This strategic move marks a significant expansion for the New York-based company, allowing it to extend its integrated care model from urban […]
Cleveland Clinic Validates ROI of AI Scribing Through Large-Scale Implementation and Clinician Retention Metrics
The financial burden of integrating artificial intelligence into clinical workflows has long been a primary hurdle for healthcare administrators, yet Cleveland Clinic appears to have cracked the code on proving the technology’s worth. By successfully onboarding more than 4,000 ambulatory care clinicians onto Ambience Healthcare’s ambient scribing platform in a mere four-month window, the world-renowned […]
Abcuro Adds $66M to Try Again in Rare Inflammatory Disorder With No Approved Drugs
Abcuro, a clinical-stage biotechnology company headquartered in Newton, Massachusetts, has announced the successful closing of a $66 million Series D financing round, a move intended to breathe new life into its lead program following mixed results in a pivotal clinical trial. The fresh capital is earmarked for the continued development of ulviprubart, a first-in-class monoclonal […]
The Rise of Consumer Diagnostics and the Transformation of Modern Healthcare Delivery
The global healthcare landscape is currently undergoing a seismic shift as diagnostic testing moves out of the traditional laboratory setting and directly into the hands of the consumer. This transition, accelerated by the exigencies of the Covid-19 pandemic, has evolved from a temporary emergency measure into a permanent fixture of the modern medical infrastructure. According […]
Slate Medicines to Enter Public Markets Through Fulcrum Therapeutics Merger to Advance Next-Generation Dual-Targeting Migraine Therapies
Slate Medicines, a Raleigh-based biotechnology firm specializing in neurovascular disorders, has announced a definitive merger agreement with Nasdaq-listed Fulcrum Therapeutics. This strategic business combination serves as a pivotal moment for Slate, providing the company with a streamlined path to the public markets and a significant capital infusion to accelerate its pipeline of next-generation migraine treatments. […]
